Evidence map›Paper›PMID 42152043›Full record

ArticleBMC veterinary research2026

Cross-sectional study of calves from Norwegian dairy herds with enzootic pneumonia: pathogen occurrence, antimicrobial resistance, culture result interpretation, and sampling site agreement.

Lise M Ånestad, Silje E Falkeid, Veslemøy S Oma, Randi T Garmo, Ane M Bjelland, Amelia R Woolums, Maria Stokstad, Thea B Klem

Abstract read
In one paragraph

Article in BMC veterinary research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Genomic diversity and virulence ofMicrobial genomics · 2026
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lise M ÅnestadNorwegian Veterinary Institute, Pb. 64, Ås, N-1431, Norway. lise.marie.anestad@vetinst.no.
Silje E FalkeidDepartment of Production Animal Clinical Sciences, Norwegian University of Life Sciences, Pb. 5003, Ås, 1432, Norway.
Veslemøy S OmaDepartment of Production Animal Clinical Sciences, Norwegian University of Life Sciences, Pb. 5003, Ås, 1432, Norway.
Randi T GarmoR&D Department, Farm Advisory Services, TINE SA, BTB-NMBU, Pb. 5003, Ås, 1432, Norway.
Ane M BjellandDepartment of Bacteriology, Norwegian Institute of Public Health, Pb. 222, Skøyen, Oslo, 0213, Norway.
Amelia R WoolumsDepartment of Pathobiology and Population Medicine, Mississippi State University, 240 Wise Center, Mississippi State, Mississippi, 39762, USA.
Maria StokstadDepartment of Production Animal Clinical Sciences, Norwegian University of Life Sciences, Pb. 5003, Ås, 1432, Norway.
Thea B KlemNorwegian Veterinary Institute, Pb. 64, Ås, N-1431, Norway.

Funding

The Norwegian Research Funding for Agriculture and Food Industry The Research Council of Norway, project no. 303127
6 · The paper itself

Abstract

backgroundEnzootic pneumonia in calves is associated with pathogens such as Pasteurellaceae bacteria and Mycoplasmopsis bovis. Some of these bacteria are commensals in healthy calves, complicating culture interpretation, discouraging laboratory diagnostic use, and limiting knowledge of their impact. This study aimed to investigate the occurrence and antimicrobial resistance pattern of respiratory pathogens in calves from dairy herds with enzootic pneumonia. Culture results between upper and lower airway sites in healthy and diseased calves were also compared to evaluate their diagnostic value. A cross-sectional study was conducted on 131 calves (72 healthy and 59 diseased) from nine Norwegian dairy herds. Nasal swabs (NS), nasopharyngeal swabs (NPS), and serum were obtained from each calf, and bronchoalveolar lavage (BAL) from 113 calves.

resultsAt the calf level, Pasteurella multocida was present in 60%, Mannheimia haemolytica in 55%, and Histophilus somni in 3%. At the sampling site level, from NS, NPS, and BAL, P. multocida was detected in 47%, 45%, and 27%, and M. haemolytica in 46%, 37%, and 8%, respectively. H. somni was detected in ≤ 2% per site. P. multocida appeared as pure culture in 73% (22/30) of positive BAL cultures. Serum antibodies to M. bovis were not detected. Most Pasteurellaceae isolates were susceptible to penicillin and other common pneumonia antimicrobials (disc diffusion). The exceptions were penicillin-resistant M. haemolytica isolates in two calves. Logistic regression identified an association between dominant, abundant cultures of P. multocida from BAL and clinical disease. Agreement for P. multocida detection between NS and NPS cultures and BAL was fair (kappa). Positive predictive values of P. multocida culture results at different abundance levels in NS and NPS, relative to BAL, were at most 49%.

conclusionP. multocida was the predominant bacterium in lungs of calves from Norwegian dairy herds with enzootic pneumonia, and its abundance in the lungs may help differentiate infection from colonization in clinically diseased calves. M. haemolytica and H. somni appeared to have less clinical impact. Antimicrobial resistance appeared to be low. Upper airway cultures were inaccurate predictors of bacterial presence and abundance in the lungs and must be interpreted carefully alongside other diagnostic tools.

Indexed as

Pneumonia of Calves, EnzooticAnimalsAnti-Bacterial AgentsBronchoalveolar Lavage FluidCattleCross-Sectional StudiesDrug Resistance, BacterialFemaleMannheimia haemolyticaMicrobial Sensitivity TestsNorwayPasteurella multocidaAnti-Bacterial AgentsBacterial abundanceBovine respiratory disease (BRD)Bronchoalveolar lavageDairy calvesDiagnosticsMannheimia haemolyticaNasal swabNasopharyngeal swabPasteurella multocidaPenicillin

Identifiers

PMID42152043
PMCPMC13523226

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.